Literatur
Kwo PY, Lawitz EJ et al (2010) Efficacy of Boceprevir, an NS 3 protease inhibitor, in combination with peginterferon alfa 2b and Ribavirin in treatment-naïve patients with genotype 1 hepatitis C infection (SPRINT 1): an open-label, randomized multicentre phase 2 trial. Lancet 376: 705–716
Hézode C, Forestier N (2009) Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med 360: 1939–1950
McHutchison JG, Manns MP (2009) Telaprevir for previously treated chronic HCV infection. N Engl J Med 362: 1292–1303
Erklärung zum Interessenkonflikt
Der Autor gibt an, Reisekostenunterstützung der Firma Essex Deutschland erhalten zu haben.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schiedermaier, P. Proteinaseninhibitoren. Gastroenterologe 6, 502–503 (2011). https://doi.org/10.1007/s11377-011-0591-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-011-0591-4